Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
2.
Cureus ; 15(3): e36885, 2023 Mar.
Article in English | MEDLINE | ID: mdl-37128536

ABSTRACT

Introduction Myocardial infarction, a major consequence of coronary artery disease, is an important cause of in-hospital mortality and morbidity worldwide. Blood neutrophil-to-lymphocyte ratio (NLR) is a novel laboratory marker of systemic inflammation that can predict the severity and mortality in various non-cardiovascular illnesses, including malignancy and infective pathology. We sought to evaluate its potential in predicting the outcome in hospitalized patients with myocardial infarction.  Material and methods The index study was conducted at Silchar Medical College and Hospital from June 1, 2021 to May 31, 2022, with the aim of evaluating the role of NLR in determining the outcomes of ST-elevation myocardial infarction (STEMI). A total of 110 patients fulfilling the requisite criteria and admitted to the cardiology and medicine departments of the hospital with evidence of STEMI were included in the study and evaluated for the relationship of NLR with various outcome variables in STEMI.  Results Out of 110 patients, 69.1% were males. The mean age of the study population was 58.2±15.3 years. The baseline characteristics and risk factors of patients who survived the acute attack of STEMI and those who died from complications of STEMI were similar. Laboratory parameters which correlated with worse outcomes included a higher fasting triglyceride level (173.4 mg vs. 215.6 mg, p < 0.001), a higher blood neutrophil count at baseline, 24 hours and 72 hours (70.1% vs. 69.04%, 66.3% vs. 75.2%, 81.6% vs. 73.8%, p<0.05), a higher NLR value at baseline, 24 hours and 72 hours (2.91 ± 1.13 vs. 3.19 ± 2.32, 2.39 ± 0.74 vs. 5.56 ± 4.11, 5.1 ± 4.38 vs. 3.01 ± 1.02, p < 0.05). Among patients hospitalized with STEMI who had high NLR, had significantly elevated incidence of complications, including a higher acute, left ventricular failure (42.8% vs. 35.9%; p < 0.05) as well as increased risk of mortality (66.7% vs. 33.3%; p < 0.05) compared to low NLR group.  Conclusion NLR can predict the outcome among STEMI patients in terms of morbidity and mortality and correlates with poor left ventricular function. NLR can serve as a potential tool for early identification and efficient triage of STEMI patients during initial presentation to the ED. Its utility is more so in resource-constrained developing countries with limited access to health care. The significant advantage of NLR is its easy accessibility, rapid turnaround time, and inexpensiveness.

3.
Cureus ; 15(4): e38095, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37252583

ABSTRACT

Background Unraveling sepsis remains the holy grail of clinical medicine and the commonest cause of in-hospital mortality worldwide. Various newer biomarkers have emerged in recent years that aid in the diagnosis and prognostication of sepsis. However, the widespread use of these is limited by availability, cost, and long turnaround times. Considering the crucial role of hematological parameters in infectious conditions, the present study aimed to evaluate the association of various platelet indices with the severity and outcomes in patients diagnosed with sepsis. Methods This was a single-center, prospective, observational study comprising 100 consecutive patients who fulfilled the selection criteria in the emergency department of a tertiary care hospital from June 2021 to May 2022. All patients underwent history taking, physical examination, and necessary laboratory investigations, including complete blood counts, biochemistry panel, and radiographic and microbiological tests. A detailed assessment of various platelet indices (platelet count, mean platelet volume, and platelet distribution width) was performed, and its association with outcomes was derived. The Sequential Organ Failure Assessment (SOFA) score was recorded for all patients. Results The majority of the study population was male (52%) with a mean age of 48.05±19.27 years. Respiratory infection (38%) was the most common origin of sepsis followed by genitourinary infections in 27%. The mean platelet count on admission was 1.83±1.21 lakhs/mm3. The incidence of thrombocytopenia (<1.5 lakhs/ mm3) in our study sample was 35%. The overall in-hospital mortality of the study group was 30%. Thrombocytopenia was significantly associated with a higher SOFA score (7.4±3 vs. 3.7±1.9, P<0.05), longer hospital stays (10.8±4.6 vs. 7.8±3.9; p<0.05), and mortality (17 vs. 13; p<0.05). The change in platelet count, platelet distribution width, and mean platelet volume from Day 1 to Day 3 also correlated with outcomes. There was a decrease in platelet count among the non-survivors compared to an increase in platelet count among survivors from Day 1 to Day 3 (p<0.05). Similarly, the change in platelet distribution width showed a decreasing trend among the survivors compared to an increasing trend among the non-survivors (p<0.05). The mean platelet volume of non-survivors increased from Day 1 to Day 3 compared to a downward trend among the survivors (p<0.05). Conclusion Septic patients with thrombocytopenia on admission had a higher SOFA score and were associated with worse outcomes. Additionally, platelet indices, such as platelet distribution width and mean platelet volume, serve as important prognostic markers among sepsis patients. Change in these parameters from Day 1 to Day 3 also correlated with outcomes. These indices are simple and affordable, allowing for their serial assessment to aid in the prognosis of sepsis.

4.
J Assoc Physicians India ; 70(4): 11-12, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35443413

ABSTRACT

Stroke is one of the major health problems with major disability and loss of daily life. Serum ferritin damages the ischemic part of the brain by production of free radicals. The generation of free radical hydroxyl is catalyzed by iron released from the intracellular stores like ferritin during ischemia. Increase in ferritin may also cause progression of stroke by enhancing the release of glutamate from the brain cells. Glutamate triggers biochemical reactions that lead to brain cell death including the production of free radical in the brain tissue. The inflammatory marker ferritin has gained clinical interest as a prognostic marker in acute ischemic stroke. MATERIAL: The study was a hospital based cross sectional study conducted in 100 consecutive cases of acute ischemic stroke meeting the selection criteria. Serum ferritin was measured as soon as patient got admitted in the hospital. National Institute of Health Stroke Scale(NIHSS) scoring was applied at the time of admission and these patients were grouped into mild, moderate and severe. Modified Rankin Scale(MRS) was applied to know the recovery of the patients after 4 weeks. OBSERVATION: The minimum and maximum mean values of serum ferritin in the study were 31.7 and 511.5 respectively, with an average mean of 328.33. 61(61%) cases had high serum ferritin values and 39 (39%) cases had normal serum ferritin. Among the 61 cases having high serum ferritin levels, 26 (40%) were in moderate category and 35(60%) were in severe category of NIHSS. On the other hand, among the remaining 39 cases who had normal serum ferritin, all the 39 cases come under moderate group and none in severe group. Out of 61 cases with high serum ferritin, 12 cases were in good outcome category and 49 cases in poor outcome category of MRS scores. CONCLUSION: Pearson's r correlation reveals positive correlation between serum ferritin and NIHSS score(p value =0.00001). Pearson's r correlation analysis also reveals positive correlation between serum ferritin and MRS (p value =0.00001). The patients with higher serum ferritin levels at admission tend to deteriorate more when compared to patients with normal levels. Thus serum ferritin can be used as a prognostic marker in acute ischemic stroke patients.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Cross-Sectional Studies , Ferritins , Glutamic Acid , Humans , Ischemia/complications , Prognosis , Prospective Studies , Severity of Illness Index , Stroke/etiology , Treatment Outcome
5.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 3): 5515-5517, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36742637

ABSTRACT

Foreign body (FB) denture with 3 teeth impacted in the esophagus for 2 months without any obvious symptoms and signs is being reported. The FB, 4*3 cm was removed 26 cm from the upper incisor with rigid esophagoscope. The post-operative period was uneventful, and follow up endoscopy demonstrated normal findings.

6.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 2978-2984, 2022 Oct.
Article in English | MEDLINE | ID: mdl-34075334

ABSTRACT

To study the incidence of the smell and taste disturbance in the COVID-19 patients and a follow up at 4 months to observe for the duration of resolution of these symptoms. This is a multicentric prospective study carried out in 3 different countries, from April, 2020 to January, 2021. The COVID-19 positive patients, aged between 15 and 60 years, were inquired about the presence of any smell or taste related symptoms. The same patients were followed up with the telephonic interview after 2 months and then after 4 months, respectively. The duration of resolution of the smell and taste disturbance symptoms was noted. Total of 188 COVID-19 positive patients, average age 33.1 ± 1.7 years, 54.2% males and 45.8% female were included in the study. The smell disturbance was present in 60.6% (hyposmia 36.1%, anosmia 20.2%, and parosmia 4.2%) and taste disturbance in 28.7% of patients (hypogeusia 20.2%, ageusia 6.9%, and parageusia 1.6%). There was improvement of anosmia by 97.4, hyposmia by 95.6%, parosmia by 100%, ageusia by 100%, hypogeusia 94.8%, and parageusia by 66.7%, at 4 months follow up. The present study concludes that the smell and taste disturbances are one of the main early presenting features of the COVID-19 infection. The temporary effect of the COVID-19 infection on the olfactory and gustatory pathway was also highlighted with more than 95% patients improving at 4 months of follow up.

7.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 3186-3192, 2022 Oct.
Article in English | MEDLINE | ID: mdl-34692450

ABSTRACT

During this COVID-19 pandemic, except steroid, none of the therapeutic measures have showed any evidence of efficacy. Traditionally jala-neti using lukewarm salted water remains a yogic way of maintaining upper airway hygiene. Saline irrigation decreases the concentration of inflammatory mediators (e.g. histamine, leukotriene etc.) in nasal secretions, reduces the severity and frequency of sinusitis, reduce need of antibiotic therapy and restores competency of nasal mucosa. Jala-neti is an integral part of six cleansing techniques of yogic kriyas practised in India since thousands of years. Jala-neti can clean the upper airways, prevents colonization of infectious agents, removes foreign bodies, prevents stasis of mucous and subsequently enhances the drainage of paranasal sinuses and maintain health. Regular practice of Jala neti improves nasal symptoms and overall health status of patients with sinusitis. Jala-neti sample can even be used for COVID-19 diagnosis. Povidone iodine (PVP-I) has been utilized as a time tested antimicrobial agent with broad spectrum coverage against wide range of bacteria and viruses. Anti-SARS-CoV-2 action of PVP-I was seen at a concentration as low as 0.45%. PVP-I is generally well tolerated upto 5%, however nasal ciliotoxicity is reported at this concentration, however, this toxicity is not reported with lower concentrations(1.25% and 0.5%). So, theoretically, by using neti-kriya with povidone iodine (0.5-1%) as irrigation solution can combine and enhance the protection against COVID-19 and this can be an important armor in the fight against COVID-19. However, this hypothesis needs to be validated in real life clinical trial scenario before implementing.

8.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 3036-3042, 2022 Oct.
Article in English | MEDLINE | ID: mdl-34277385

ABSTRACT

To evaluate the hearing status of COVID-19 patients and compare with control group. Prospective study carried out in 9 institutes. The pure tone audiogram and impedance audiometry of COVID-19 patients performed initially and at 3 months follow up. The control group consisted COVID-19 negative individuals with no history of ear related diseases. The average of air and bone conduction threshold (AC and BC) were compared between the COVID-19 patients and control group using independent t-test with a p value of less than 0.05 considered significant. Total of 331 patients, age 32 ± 4.3 years, 66.7% males and 33.3% females were included in the study. There were 80 individuals in the control group. Aural symptoms were, tinnitus in 1.8%, aural fullness in 1.4%, hearing loss in 3. 9%, and ear ache in 1.8% were present initially, resolved at 3 months follow up. The impedance audiometry demonstrated type B and type C curve in 5.1% and 1.15% ears, and out of these 64.7% and 40% improved at 3 months follow up respectively. No significant difference observed between the average AC and BC of the COVID-19 patients and control group. The COVID-19 infection may present with aural symptoms; however, it was concluded that there was no significant difference in the hearing status of the COVID-19 positive patients in comparison to the control group. The presence of some changes in the normal functioning of the eustachian tube and middle ear in the COVID-19 infection was also highlighted.

9.
J Crit Care ; 67: 172-181, 2022 02.
Article in English | MEDLINE | ID: mdl-34808527

ABSTRACT

Ferritin is a known inflammatory biomarker in COVID-19. However, many factors and co-morbidities can confound the level of serum ferritin. This current metaanalysis evaluates serum ferritin level in different severity levels in COVID-19. Studies evaluating serum ferritin level in different clinical contexts (COVID-19 vs. control, mild to moderate vs. severe to critical, non-survivor vs. survivor, organ involvement, ICU and mechanical ventilation requirement) were included (total 9 literature databases searched). Metaanalysis and metaregression was carried out using metaphor "R" package. Compared to control (COVID-19 negative), higher ferritin levels were found among the COVID-19 patients [SMD -0.889 (95% C.I. -1.201, -0.577), I2 = 85%]. Severe to critical COVID-19 patients showed higher ferritin levels compared to mild to moderate COVID-19 patients [SMD 0.882 (0.738, 1.026), I2 = 85%]. In meta-regression, high heterogeneity was observed could be attributed to difference in "mean age", and "percentage of population with concomitant co-morbidities". Non-survivors had higher serum ferritin level compared to survivors [SMD 0.992 (0.672, 1.172), I2 = 92.33%]. In meta-regression, high heterogeneity observed could be attributed to difference in "mean age" and "percentage of male sex". Patients requiring ICU [SMD 0.674 (0.515 to 0.833), I2 = 80%] and mechanical ventilation [SMD 0.430 (0.258, 0.602), I2 = 32%] had higher serum ferritin levels compared to those who didn't. To conclude, serum ferritin level may serve as an important biomarker which can aid in COVID-19 management. However, presence of other co-morbid conditions/confounders warrants cautious interpretation.


Subject(s)
Biomarkers/blood , COVID-19 , Ferritins/blood , COVID-19/diagnosis , Humans , Regression Analysis
10.
Med Leg J ; : 258172211053697, 2021 Nov 11.
Article in English | MEDLINE | ID: mdl-34763550

ABSTRACT

The aim of this retrospective socio-demographic analysis is to identify those at higher risk of suicidal hanging in the region of Delhi and the National Capital Region. All deaths due to suicidal hanging from January 2016 to December 2019 reported in the Vardhman Mahavir Medical College and Safdarjung Hospital were included. Suicidal hanging accounted for 2.67% of total autopsied cases; 21-30 years old represented 42.62% of the victims. Male:female ratio was 1.7:1 and 38.37% of cases were from the adjoining areas of Vasant Kunj and Vasant Vihar. Therefore, a preventive strategy should focus concern on young adults, the male sex, and areas of Vasant Kunj and Vasant Vihar.

11.
Cureus ; 13(10): e18509, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34754669

ABSTRACT

Acute transverse myelitis (ATM) is a non-compressive localized inflammation involving one or more levels of the spinal cord due to various etiologies characterized by motor weakness, sensory impairments, and autonomic dysfunction. It can be idiopathic or primary or secondary due to infection, autoimmune disorder, connective tissue disorder, and uncommonly after vaccination which came to the limelight during the ongoing massive vaccine drive against coronavirus disease 2019 (COVID-19). We report a case of a 21-years-old male who presented with gradually progressive weakness of both lower limbs following urinary tract infection (UTI) with a history of similar illness in the family which improved with high dose methylprednisolone and antibiotic therapy followed by physical rehabilitation. A diagnosis of long segment ATM possibly following UTI was suggested after ruling out other secondary causes and was confirmed by magnetic resonance imaging (MRI) of the spinal cord. Asymmetric symptoms and signs with small lesions involving

12.
Indian J Pharmacol ; 53(4): 317-327, 2021.
Article in English | MEDLINE | ID: mdl-34414911

ABSTRACT

Since the onset of COVID-19 pandemic, parallel opportunistic infections have also been emerging as another disease spectrum. Among all these opportunistic infection, mucormycosis has become a matter of concern with its rapid increase of cases with rapid spread as compared to pre-COVID-19 era. Cases have been reported in post-COVID-19-related immune suppression along with the presence of comorbidity which adds on the deadly outcome. There is no systematic review addressing the issue of COVID-19-associated mucormycosis. This is the first systematic review of published studies of mucormycosis associated with COVID-19. The aim was to analyze the real scenario of the disease statement including all the published studies from first November 2019 to 30th June to analyze the contemporary epidemiology, clinical manifestations, risk factor, prognosis, and treatment outcome of COVID-19 associated rhino-orbito-cerebral-mucormycosis. A comprehensive literature search was done in following databases, namely, PubMed, Google Scholar, Scopus, and EMBASE using keywords mucormycosis, rhino orbital cerebral mucormycosis, COVID-19, and SARS-CoV-2 (from November 01, 2019 to June 30, 2021). Our study shows that, while corticosteroids have proved to be lifesaving in severe to critical COVID-19 patients, its indiscriminate use has come with its price of rhino-orbito-cerebral mucormycosis epidemic, especially in India especially in patients with preexisting diabetes mellitus with higher mortality. Corticosteroid use should be monitored and all COVID-19 patients should be closely evaluated/monitored for sequelae of immunosuppression following treatment.


Subject(s)
COVID-19/virology , Coinfection , Meningitis, Fungal/microbiology , Mucormycosis/microbiology , Nose Diseases/microbiology , Opportunistic Infections/microbiology , Orbital Diseases/microbiology , SARS-CoV-2/pathogenicity , Antifungal Agents/therapeutic use , COVID-19/immunology , COVID-19/mortality , Host-Pathogen Interactions , Humans , Meningitis, Fungal/drug therapy , Meningitis, Fungal/immunology , Meningitis, Fungal/mortality , Mucormycosis/drug therapy , Mucormycosis/immunology , Mucormycosis/mortality , Nose Diseases/drug therapy , Nose Diseases/immunology , Nose Diseases/mortality , Opportunistic Infections/drug therapy , Opportunistic Infections/immunology , Opportunistic Infections/mortality , Orbital Diseases/drug therapy , Orbital Diseases/immunology , Orbital Diseases/mortality , Prognosis , Risk Assessment , Risk Factors , SARS-CoV-2/immunology
13.
Cureus ; 13(11): e19976, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34984135

ABSTRACT

Introduction As per the COVID-19 treatment guidelines of India, remdesivir and convalescent plasma therapy (CPT) are indicated in moderate and severe patients. In this study, we have evaluated the comparative safety and efficacy of remdesivir versus remdesivir CPT combination and effect of early versus late initiation of remdesivir. Materials and methods A hospital-based observational study was conducted among hospitalized moderate and severe COVID-19 patients treated with either remdesivir and/or CPT as per national guidelines. Response to therapy was evaluated in terms of mortality, mechanical ventilation requirement, ICU requirement, and safety. Results and observations A total of 95 moderate and severe COVID-19 patients on remdesivir (n=35) or remdesivir + CPT combination (n=60) were included. Both the remdesivir and remdesivir + CPT groups were comparable in terms of baseline characteristics, however, proportion of patients with baseline serum creatinine >1.5 was higher in the remdesivir group. No difference was seen between both the groups in terms of mortality, mechanical ventilation requirement, ICU requirement, and safety parameters in the overall moderate and severe COVID-19 populations and when each of these severity categories (moderate and severe) were analyzed separately. Early initiation (<9 days from symptom onset) of remdesivir was associated with better treatment outcome in terms of mortality and requirement of ICU. Post-therapy shortness of breath and LFTs (liver function tests) elevation was more in the late initiation of remdesivir group, which may be due to the lack of efficacy and subsequent disease progression or a direct effect of the drug. The beneficial effect of remdesivir was maintained even after adjustment for important prognostic factors and baseline imbalances (age, sex, disease severity, CPT use, and serum creatinine level). Conclusions Early initiation of remdesivir was associated with clinical benefit in terms of mortality and mechanical ventilation requirement. However, addition of convalescent plasma therapy as an additional therapeutic modality to remdesivir was not found to be beneficial.

14.
Indian J Pharmacol ; 53(6): 484-488, 2021.
Article in English | MEDLINE | ID: mdl-34975137

ABSTRACT

The current study was conducted to determine the role of C-reactive protein (CRP) and lactate dehydrogenase (LDH) as prognostic-marker and outcomes of different pharmacotherapeutic agents among patients with cerebrovascular accident (CVA). A hospital-based observational study was conducted and patients with CVA admitted were included. Serum-CRP on admission correlated positively with modified Rankin score (mRS) (r = 0.9, P < 0.001) in ischemic stroke, whereas no correlation between serum LDH with mRS (r = 0.1, P = 0.5) was observed. Neither CRP nor LDH was helpful in predicting the outcome in hemorrhagic stroke. The use of Vitamin B12 was associated with favorable outcome in ischemic CVA cases and use of folic acid was associated with favorable outcome among hemorrhagic-CVA patients.


Subject(s)
C-Reactive Protein/metabolism , L-Lactate Dehydrogenase/blood , Stroke/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Female , Hospitalization , Humans , Male , Middle Aged , Prospective Studies , Stroke/blood , Stroke/drug therapy
15.
J Nepal Health Res Counc ; 18(1): 93-98, 2020 Apr 20.
Article in English | MEDLINE | ID: mdl-32335600

ABSTRACT

BACKGROUND: Cardiovascular diseases are the dominant cause of morbidity and mortality worldwide. In 2008, cardiovascular deaths represented 30% of all global deaths, with more than 80% of deaths in developing countries. There is increase in incidence of hypertension, atherosclerosis, stroke, chronic heart failure and atrial fibrillation. The objective of this study is to find the pattern of cardiovascular diseases among patients admitted in cardiac ward. METHODS: A retrospective analysis of records of admitted patients from 1st January 2016 - 30th December 2017 was conducted in Cardiology ward of Manipal Teaching Hospital, Pokhara, Nepal. A total of 2268 patients' data were taken from the ward register. The data was collected and analyzed with descriptive and inferential statistics using SPSS 18.0 version during the period from 1st June to 30th August 2018. RESULTS: The age ranged between 12 to 95 years with a mean (SD) is 61.23(16.34 years). More than half (51%) of the patients were female gender. Forty-six percentages of the patients were in the age group of 56 - 75 years. More than 1/3rd (35%) were diagnosed with Ischemic heart disease (IHD) followed by hypertension (22.8%) and arrhythmia(13.4%). There was a significant association between age and gender with the pattern of cardiovascular disease. CONCLUSIONS: Ischemic heart disease, hypertension and arrhythmia were the major causes of hospitalization. Preventive measures at community and personal level focusing on the risk factors management of ischemic heart disease will alleviate the burden of ischemic heart disease.


Subject(s)
Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/physiopathology , Adolescent , Adult , Aged , Aged, 80 and over , Cardiovascular Diseases/epidemiology , Child , Comorbidity , Female , Hospitals, Teaching , Humans , Male , Medical Audit , Middle Aged , Nepal/epidemiology , Retrospective Studies , Tertiary Healthcare , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL